Investors and Partners

Centrose is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer and other diseases where current therapies are failing. 

Centrose discovered the first drug targeting system where the drug and the targeting moiety work synergistically. The System is called the Extracellular Drug Conjugate System or EDC. The EDC System has the potential to revolutionize targeted drug therapy by lowering off target side effects of the drug without interfering with drug potency.

Either as a partner or investor, we look forward to having your help in bringing safer and more effective therapies to the patient.